Skip to main content
SpringerLink
Log in

Treatment options limited for patients with adult T cell leukaemia

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hermine O, Wattel E, Gessain A, et al. Adult T cell leukaemia: a review of established and new treatments. BioDrugs 1998 Dec; 10(6): 447–62

    Article  PubMed  CAS  Google Scholar 

  2. Shimoyama M, and members of the lymphoma study group. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia/lymphoma. Br J Haematol 1991; 79: 428–39

    Article  PubMed  CAS  Google Scholar 

  3. Bunn Jr PA, Schechter GP, Jaffe E, et al. Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N Engl J Med 1983; 309(5): 257–64

    Article  PubMed  Google Scholar 

  4. Shimoyama M. Treatment of patients with adult T-cell leukaemialymphoma: an overview. In: Takasuki K, Hinuma Y, Yoshida M, editors. Advances in adult T-cell leukaemia and HTLV-I research: Japan scientific societies press. Gonn Monographs on Cancer Research 1992; 39: 43-56

  5. Gill PS, Harrington Jr W, Kaplan MH, et al. Treatment of adult T-cell leukaemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 1995; 332(26): 1744–8

    Article  PubMed  CAS  Google Scholar 

  6. Hermine O, Bouscary D, Gessain A, et al. Brief report: treatment of adult T-cell leukaemia-lymphoma with zidovudine and interferon alfa. N Engl J Med 1995; 332(26): 1749–51

    Article  PubMed  CAS  Google Scholar 

  7. Bazarbachi A, Hermine O. Treatment with a combination of zidovudine and alfa-interferon in naive and pretreated adult T-cell leukaemia/lymphoma patients. J Acquir Immun Defic Synd Hum Retroviral 1996; 13 Suppl. 1: S186–90

    Article  CAS  Google Scholar 

  8. Oguma S, Imamura Y, Kusumoto Y. Accelerated declining tendency of human T-cell leukaemia virus type I carrier rates among younger blood donors in Kumamoto, Japan. Cancer Res 1992; 52: 2620–6

    PubMed  CAS  Google Scholar 

  9. Yamaguchi K. Human T-lymphotropic virus type I in Japan. Lancet 1994; 343: 213–6

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Treatment options limited for patients with adult T cell leukaemia. Drugs Ther. Perspect 15, 11–14 (2000). https://doi.org/10.2165/00042310-200015030-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200015030-00004

Keywords

Search

Navigation